close 73% din conturile investitorilor de retail pierd bani atunci când tranzacționează CFD-uri cu acest furnizor. Investițiile implică riscuri și nu sunt potrivite pentru toți investitorii. CFD-urile sunt instrumente complexe și prezintă un risc ridicat de a pierde rapid bani din cauza efectului de levier. 73% din conturile investitorilor de retail pierd bani atunci când tranzacționează CFD-uri cu acest furnizor. Ar trebui să iei în considerare dacă înțelegi modul în care funcționează CFD-urile și dacă îți poți permite asumarea riscului ridicat de a-ți pierde banii.
Change languageRomână
Dashboard

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

Home・Listă Acțiuni・Karyopharm Therapeutics Inc
Search

Karyopharm Therapeutics Inc

Închisă

SectorSănătate

9.53 3.47

Puternic Cumpărare

Preț actualizat 19 feb. 2026, 20:59 UTC

CumpărăVinde

Rezumat

Modificarea prețului

24h

Curent

Minim

9.53

Maxim

9.53

Indicatori cheie

By Trading Economics

Venit

4.1M

-33M

Vânzări

6.1M

44M

EPS

-2.227

Marjă de profit

-75.213

Angajați

279

EBITDA

1.8M

-23M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+72.39% upside

Statistici piață

By TradingEconomics

Capitalizare de piață

55M

157M

Deschiderea anterioară

6.06

Închiderea anterioară

9.53

Sentimentul știrilor

By Acuity

40%

60%

129 / 351 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bullish Evidence

5.9501 / 7.66 Suport & Rezistență

Karyopharm Therapeutics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

20 feb. 2026, 17:37 UTC

Achiziții, Fuziuni, Preluări

Paramount Regulatory Waiting Period for Warner Bid Expires -- Update

DJ

Citește

20 feb. 2026, 16:18 UTC

Principalele dinamici ale pieței

Footwear Stocks Rise After Supreme Court Strikes Down Tariffs

DJ

Citește

20 feb. 2026, 23:12 UTC

Achiziții, Fuziuni, Preluări

FERC Authorizes TXNM Energy Acquisition by Blackstone Infrastructure

DJ

Citește

20 feb. 2026, 22:12 UTC

Câștiguri

Equinox Gold: Announces Filing of 2025 Audited Fincl Statements

DJ

Citește

20 feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Citește

20 feb. 2026, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

DJ

Citește

20 feb. 2026, 21:23 UTC

Câștiguri

These Stocks Are Today's Movers: Grail, Corning, Comfort Systems USA, Opendoor, Akamai, Chemours, and More -- Barrons.com

DJ

Citește

20 feb. 2026, 21:20 UTC

Market Talk

Century Aluminum Backs Trump's Tariffs After SCOTUS Ruling -- Market Talk

DJ

Citește

20 feb. 2026, 21:01 UTC

Achiziții, Fuziuni, Preluări

Want to Win the Warner Bros. Discovery Takeover Battle? 'Walk Away Now.' -- Barrons.com

DJ

Citește

20 feb. 2026, 20:38 UTC

Market Talk

U.S. Natural Gas Gains Ahead of Chilly Weekend -- Market Talk

DJ

Citește

20 feb. 2026, 20:17 UTC

Market Talk

Oil Futures Mixed As Market Awaits U.S.-Iran Moves -- Market Talk

DJ

Citește

20 feb. 2026, 20:11 UTC

Market Talk

Traders Await Word on USMCA Exemption For Trump's Global 10% Tariff -- Market Talk

DJ

Citește

20 feb. 2026, 19:59 UTC

Market Talk

U.S. Tariff Ruling Could Make Things Worse for Mexico -- Market Talk

DJ

Citește

20 feb. 2026, 19:58 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Netflix Seen as Not Needing Warner Bros. Deal -- Market Talk

DJ

Citește

20 feb. 2026, 19:49 UTC

Market Talk

Mexico's Revised 4Q GDP Expected to Confirm Pick-Up -- Market Talk

DJ

Citește

20 feb. 2026, 19:09 UTC

Market Talk

Precious Metals Settle Higher After Tariff Ruling -- Market Talk

DJ

Citește

20 feb. 2026, 19:00 UTC

Market Talk

U.S. Oil, Gas Rig Counts Unchanged on Week -- Market Talk

DJ

Citește

20 feb. 2026, 18:28 UTC

Market Talk

Ontario Premier Warns Fight Against U.S. Tariffs Isn't Over -- Market Talk

DJ

Citește

20 feb. 2026, 18:20 UTC

Market Talk

Tariff Ruling Seen Positive for Some Retailers, Mixed for Others -- Market Talk

DJ

Citește

20 feb. 2026, 18:05 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

DJ

Citește

20 feb. 2026, 18:04 UTC

Market Talk

Trade Uncertainty in Canada to Remain Until USMCA Resolved -- Market Talk

DJ

Citește

20 feb. 2026, 17:38 UTC

Market Talk

Canada's Small Firms Look Toward Increased U.S. Tariff Opposition -- Market Talk

DJ

Citește

20 feb. 2026, 17:24 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Citește

20 feb. 2026, 17:24 UTC

Market Talk

Correction to Treasury Yields Fall Market Talk

DJ

Citește

20 feb. 2026, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

DJ

Citește

20 feb. 2026, 16:53 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

DJ

Citește

20 feb. 2026, 16:53 UTC

Market Talk

Canada Dollar Steady, Market Focus on USMCA Review -- Market Talk

DJ

Citește

20 feb. 2026, 16:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Citește

20 feb. 2026, 16:45 UTC

Market Talk

U.K. Public Finances Supportive of Gilts in Near-Term -- Market Talk

DJ

Citește

20 feb. 2026, 16:40 UTC

Market Talk

Trade Threats Facing Canada Not Removed by Supreme Court's Ruling -- Market Talk

DJ

Citește

Comparație

Modificare preț

Karyopharm Therapeutics Inc Așteptări

Obiectiv de preț

By TipRanks

72.39% sus

Prognoză pe 12 luni

Medie 16.67 USD  72.39%

Maxim 23 USD

Minim 12 USD

În baza a 4 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruKaryopharm Therapeutics Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

4 ratings

4

Cumpărare

0

Păstrare

0

Vânzare

Ținând cont de 4 analiști care au acordat evaluări ale acțiunilor Karyopharm Therapeutics Inc - Dist în ultimele 3 luni.

Scor tehnic

By Trading Central

5.9501 / 7.66Suport & Rezistență

Termen scurt

Bullish Evidence

Recent bullish events outweigh bearish events.

Termen mediu

Strong Bearish Evidence

All events are bearish.

Termen lung

No Evidence

There are no events.

Sentiment

By Acuity

129 / 351 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Alte acțiuni din sector

LLY

Eli Lilly and Co.

1,008.73

↓-1.37%

JNJ

Johnson and Johnson

242.5

↓-1.77%

ABBV

AbbVie Inc

224.75

↑ +0.24%

NVS

Novartis AG

162.69

↓-0.47%

MRK

Merck & Co Inc.

122.26

↑ +0.39%
help-icon Live chat